By Ben Adams
After its mega $424 million IPO this summer, blood cancer focused Legend Biotech is making a big change at the top.
read more
By Amirah Al Idrus
Chalk one up for Immunic Therapeutics’ lead asset—the drug outshone placebo at reducing damage to myelin, the fatty substance that coats and protects nerve fibers, in patients with the relapsing form of multiple sclerosis. With these topline data in hand, the company will continue gearing up for a phase 3 program.
read more
By Nick Paul Taylor
Aslan Pharmaceuticals has named Kenneth Kobayashi as its chief medical officer. The appointment sees Kobayashi switch from developing Dermira’s anti-IL-13 drug to advancing Aslan’s would-be rival.
read more
By Ben Adams
Preclinical protein degradation biotech Kymera Therapeutics has a great year, nabbing a $102 million round for its march to the clinic, as well as a major tie up with French Big Pharma Sanofi.
read more
By Conor Hale
Siemens Healthineers has moved to take over Varian Medical Systems, makers of radiation therapy hardware and software, to build out its cancer care offerings and provide a platform spanning screening and diagnosis to treatment delivery and recovery.
read more
Sponsored by: Catalent
In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management.
Sponsored by: Lonza Pharma & Biotech
A novel spray-dried dispersion platform has been developed to faciliate high drug load applications
Sponsored by: Catalent
Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study.
Sponsored by: Catalent
Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study.
Sponsored by: Catalent
Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study.
